Prolia 60 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F9MJ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,961
Award facts
- Contract value 100% obligated
- $23,961.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,961.12 to Amerisourcebergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of January 23, 2026. Performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order operates under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor that supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to federal agencies. The company's extensive contract portfolio with DLA demonstrates its capability to meet stringent federal procurement requirements for critical medical commodities supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Cencora maintains a significant IDC with DLA valued at $999,999,999.00 through December 31, 2031, reflecting the company's strategic importance within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9MJ5?
SPE2DR26F9MJ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9MJ5 worth?
The government has obligated $23,961 on SPE2DR26F9MJ5.
Is contract SPE2DR26F9MJ5 an order under another contract?
Yes. SPE2DR26F9MJ5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MJ5 competed?
The extent of competition for SPE2DR26F9MJ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award